Excellent presentation by @sophiemerrick1! RAMPART: adjuvant durvalumab worsened overall QoL at week 16 vs active monitoring after RCC surgery, with no difference at month 15. Patient experience matters in adjuvant treatment decisions! #ESMO26 @oncoalert @myESMO